Clinical performance of a rapid test compared to a microplate test to detect total anti SARS-CoV-2 antibodies directed to the spike protein
Detection Principle
ImmunoAssay-Antibody
Target
total Ab vs S
Testing Method Category
Mixed
Testing Method
kits (Wantai ELISA and Rapid test)
Testing Method - Additional Info
2 serological assays that detect total anti-SARS-CoV-2 antibodies. One is a rapid immunochromatographic test (SARS-CoV-2 Ab Rapid Test, Beijing Wantai Biological Pharmacy Ent, Bejing, China) and the other is a microplate assay (SARS-CoV-2 Ab ELISA, Beijing Wantai Biological Pharmacy Ent, Bejing, China).
Reported Performance
Specificity: 100% (both); Sensitivity 87 % (Rapid test, overall), 93% (Rapid test, >15 dpo), 100 % (ELISA, overall), 100% (ELISA, >15dpo)
Sample Size
99 samples
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements